コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 (the proportion of cells producing multiple effector molecules).
2 d with high fidelity by sequestration of the effector molecule.
3 phosphoinositide 3-kinase (PI3K), a key IIS effector molecule.
4 reactive oxygen species, an antileishmanial effector molecule.
5 e, in which the cytokine IL-6 is a prominent effector molecule.
6 tight junction protein and a potent anti-HCV effector molecule.
7 s either a neutralizing decoy receptor or an effector molecule.
8 ry and secondary structure and their cognate effector molecule.
9 , Rab proteins interact with proteins termed effector molecules.
10 zation and rational design of novel cereblon effector molecules.
11 of GPCRs with heterotrimeric G proteins and effector molecules.
12 colytic activity and increased expression of effector molecules.
13 low extracellular pH, helping it to secrete effector molecules.
14 egs) and T(H)17 cells and controls important effector molecules.
15 CO-caged molecule was used to deliver active effector molecules.
16 or proper counteractions through adaptor and effector molecules.
17 n of cytosolic tyrosines, which then recruit effector molecules.
18 ession, in response to synthetic non-natural effector molecules.
19 t restrains the expression of genes encoding effector molecules.
20 signals in the extracellular environment via effector molecules.
21 onal changes promoting binding of downstream effector molecules.
22 te the biochemistry of hosts by secretion of effector molecules.
23 rough the recruitment of other antimicrobial effector molecules.
24 acity to produce an array of proinflammatory effector molecules.
25 terized T6SSs, binds specifically to cognate effector molecules.
26 connecting upstream receptors to downstream effector molecules.
27 f the vaccine, with an increase in cytolytic effector molecules.
28 the ability to produce distinct patterns of effector molecules.
29 n-1 and transcription-independent control of effector molecules.
30 n, and the production of cytokines and other effector molecules.
31 interact with cargo proteins, membranes, and effector molecules.
32 phages as well as key cytokine and chemokine effector molecules.
33 as ligand) and apoptotic (cleaved caspase-3) effector molecules.
34 ge, stimulating the activation of downstream effector molecules.
35 ective signaling and defective production of effector molecules.
36 large amounts of type-2 cytokines and other effector molecules.
37 Tumor Necrosis Factor Receptor to downstream effector molecules.
38 ant differences among the complexes with the effector molecules.
39 s to enable optimal interactions with murine effector molecules.
40 ethylated at the loci of classically defined effector molecules.
41 TCH downstream targets and B-cell maturation/effector molecules.
42 teins derives from their ability to bind the effector molecules 2-oxoglutarate (2-OG) and ATP or ADP.
43 n activate immune cells by shuttling various effector molecules, a process that may be relevant to ho
44 cate that KDM5C is a conserved and druggable effector molecule across a number of NDDs for whom the u
46 ams that control expression of key cytolytic effector molecules, adhesion molecules, and cytokine and
47 -9 functioning as a potent antiviral defense effector molecule against HCMV infection and identifies
48 d activation of downstream insulin signaling effector molecules AKT and Foxo1, and decreased expressi
49 e for translocation of a wide range of toxic effector molecules, allowing predatory cells to kill bot
50 s: a receptor (aptamer) domain that binds an effector molecule and a regulatory domain (or expression
53 val by reducing intragraft expression of Th2 effector molecules and eosinophilic allograft infiltrati
54 ly polyfunctional, expressing high levels of effector molecules and exhibiting superior short-term co
55 CC secreted Th1, Th2, and Th22 cytokines and effector molecules and expressed TCR Vbeta 5.1, 16, 20,
56 modular fashion, which can be combined with effector molecules and half-life extension technologies.
57 ynapse, which mediates efficient delivery of effector molecules and intercellular signals across the
58 riptional signatures were maintained but key effector molecules and metabolic pathways were suppresse
59 ed virtually all arms, cellular players, and effector molecules and pathways involved in these crucia
60 nal properties of this subset and identified effector molecules and pathways which mediate their func
61 leptospiral proteases can deactivate immune effector molecules and represent potential targets to th
62 nti-inflammatory state; however, the biofilm effector molecules and the mechanism(s) of action respon
63 ular signaling pathways by engaging critical effector molecules and thus acts as a ligand-independent
66 that reduce the expression of cytokines and effector molecules and upregulate the expression of inhi
68 ntibody against the target, potent cytotoxic effector molecules, and conjugation of the monoclonal an
69 rate-limiting glycolytic enzymes, cytolytic effector molecules, and essential chemokine and adhesion
70 ecause IL-10 production, expression of other effector molecules, and general immune homeostasis are n
71 h pathogen recognizing receptors, cytokines, effector molecules, and granules filled with reactive ox
72 cular innate and adaptive immune cell types, effector molecules, and pathways can sometimes collectiv
74 y, they are well suited for combination with effector molecules as well as half-life extension techno
76 uPAR was physically associated with the WNT effector molecule beta-catenin on the membrane, cytoplas
80 artments through production of cytokines and effector molecules, but it is unclear how tissue site in
81 ing transcription of IFN-gamma and other key effector molecules by donor CD8 cells in the epidermis,
84 valis signature genes based on its activated effector molecules can efficiently distinguish ESCC pati
87 code transcription factors (including Tcf7), effector molecules, cell cycle regulators, and proteins
90 tion are well-defined, little is known about effector-molecules contributing to malignant expansion a
91 Tregs among CD4(+) T cells, turnover of the effector molecule CTLA-4, and their suppressive activity
92 acellular levels of the nitric oxide pathway effector molecule cyclic guanosine monophosphate (cGMP),
94 this body of work is that Arc is a critical effector molecule downstream of many molecular signaling
95 pression of a wide range of genes (including effector molecules downstream of IL-17 such as cytokines
98 al mucosal homeostasis, as well as prominent effector molecules during chronic gut inflammatory disea
100 f granzymes and perforin, which are the main effector molecules expressed by CD8(+) cytotoxic T lymph
101 The granzyme family serine proteases are key effector molecules expressed by cytotoxic lymphocytes.
103 rylation and to suppress their IL-15-induced effector molecule expression and cytolytic capacity.
104 during DC:NK cell coculture enhanced NK cell effector molecule expression as well as their cytolytic
110 IGIT on Treg cells induced expression of the effector molecule fibrinogen-like protein 2 (Fgl2), whic
114 e cytokine interleukin 13 (IL-13) is a major effector molecule for T-helper type 2 inflammation and i
115 xogenous galectin-9, in addition to being an effector molecule for Treg cells, acts synergistically w
117 in pH that accompanies the "uncaging" of an effector molecule from o-nitrobenzaldehyde, a photoisome
119 ntrinsic mechanism governed by the NF-kappaB effector molecule GADD45beta that restricts tumor-associ
120 ly induced their expression of the cytotoxic effector molecules granzyme B and perforin; their degran
121 tion, type 1 CD8 cytotoxic T cell-associated effector molecules granzyme B(+), IFN-gamma(+), TNF-alph
125 quired for the production of the key NK cell effector molecules IFN-gamma, which is important in deli
127 on of activation markers (CD69 and CD25) and effector molecules (IFN-gamma, granzyme B, and IL-10) di
129 rogram characterized by the induction of the effector molecules IL-7Ralpha, S1P1, and CCR7, but the u
132 cer treatment, and caspase-3 is an important effector molecule in NK cell-mediated apoptosis in cance
133 genic, conditions, ICOS emerges as a pivotal effector molecule in the early decision between toleranc
134 pathways, specifically placing it as a novel effector molecule in the non-canonical Wnt/PCP pathway.
139 f dithiolethione on NF-kappaB and downstream effector molecules in estrogen receptor-negative breast
140 one marrow (BM) and induce the expression of effector molecules in memory T cells, before their recru
141 eins (IFITMs) have been identified to be key effector molecules in the host type I interferon defense
142 icrobial proteins and peptides are essential effector molecules in this airway epithelial innate immu
144 bolites that bind to and regulate downstream effector molecules including lipid-regulated potassium c
146 to produce an unusual spectrum of biological effector molecules, including IL-25, eicosanoids implica
147 , creatine inhibited the induction of immune effector molecules, including iNOS, by suppressing IFN-g
150 s factor alpha-positive [TNF-alpha(+)]), and effector molecule (inducible nitric oxide synthase-posit
151 endently affecting a small group of powerful effector molecules; induction tolerance represented a mo
152 a identify endothelial JAM-A as an important effector molecule integrating atherogenic conditions to
153 n rates (<10%) and minimal production of the effector molecules interferon-gamma, interleukin-17, and
156 novel virulence mechanism, sending sRNAs as effector molecules into plant cells to silence plant imm
157 a bacterial nanomachine for the transport of effector molecules into prokaryotic and eukaryotic cells
158 ns use type III secretion systems to deliver effector molecules into the cytoplasm of a host cell.
161 interfering RNA class of small RNAs are the effector molecules involved in direct silencing of CER3
162 tinct mechanisms drive the production of Tfh effector molecules, involving IL-12p70 for IL-21 and act
163 ma (STS), we show that disruption of the IFN effector molecule IRF8 decreases pSTAT1 and increases uS
164 anism in small GTPase signaling by which the effector molecule is autoinhibited for GTPase interactio
166 teins to regulate transcription via specific effector molecules is leveraged as a coupled assay that
167 ting TLR2-MyD88 signals in T cells increased effector-molecule levels and enhanced the clearance of L
168 from exposure and detection by innate immune effector molecules like the C-type signaling lectin Dect
170 pathology, and targeting IFN-I or downstream effector molecules may be an effective therapeutic appro
171 ediated phagocytosis (CDCP) by immunological effector molecules mediated the clearance of target cell
173 Taken together, mGBP2 is an essential immune effector molecule mediating antiparasitic resistance.
174 agellin receptor TLR5 and the TLR downstream effector molecules MyD88 and TIRAP that are associated w
178 p21-activated kinase (PAK1) as a downstream effector molecule of H2.0-like homeobox (HLX), a gene fu
179 e tetraphosphate (ppGpp), which serves as an effector molecule of many processes including transcript
180 e-produced secretory IgA (sIgA), the primary effector molecule of mucosal immunity, in mice with homo
181 its antiproliferative effect by acting as an effector molecule of Ras, resulting in the inhibition of
182 iptional activity of GLI3, a transcriptional effector molecule of SHH, in cancer cell lines with auto
183 cytosolic phospholipase A(2) (cPLA(2)) as an effector molecule of Src-PLD1-PKCgamma signaling in the
184 ed the temporal transcription of RNAIII, the effector molecule of the agr quorum-sensing system.
189 ovel roles for myosin II as a key regulatory effector molecule of the pro-fibrotic phenotype, in resp
190 over, although angiotensin II is the classic effector molecule of the RAS, several RAS enzymes affect
194 human host requires mechanisms to resist the effector molecules of host immunity, which exert their b
198 e recently been identified as important host effector molecules of the type I interferon response aga
199 n has been variously interpreted as a direct effector molecule on bacterial phagosomes or on other or
200 22-producing CD4(+) T cells may express some effector molecules on the membrane, and therefore synerg
201 gulate the function of any TALE either using effector molecules or a heterodimerization reaction.
202 irectly by allowing or preventing docking of effector molecules, or directly by changing the intrinsi
204 e an important role for the immune cytotoxic effector molecule perforin in regulating this process.
205 T-cells showed increased expression of the effector molecules perforin and interferon-gamma with hi
207 ubset displaying low expression of cytotoxic effector molecules, perforin and granzyme beta, with red
212 ent resulted in the reversal of the baseline effector molecule profile comparable with MAIT cells fro
213 ored these immune cells, augmented cytotoxic effector molecules, promoted systemic inflammatory respo
214 iated critical adaptor members to downstream effector molecules, promoting successful nuclear deliver
215 function, the process by which binding of an effector molecule provokes a functional response from a
216 Due to its fast pharmacokinetics, the small effector molecules reach the malignant tissue quickly an
217 pargylglycine demonstrated that H(2)S is the effector molecule regulating Mtb survival in macrophages
219 ied many of the intracellular signalling and effector molecules required for the response to this sig
221 lence) decreased by up to 84% for two of the effector molecules, scorpine, a potent antiplasmodial pe
222 via the simultaneous measurement of a dozen effector molecules secreted from tumor antigen-specific
223 FLT3-TKD is able to activate the downstream effector molecule signal transducer and activator of tra
225 on of the TGFbeta receptor TGFbetaR1 and its effector molecule SMAD4 was required for enrichment of C
226 to infections, neutrophils rely on preformed effector molecules stored in a variety of intracellular
227 unctions and enhance the function of several effector molecules such as FcgammaR, uPAR, and CD14.
228 L-15 also resulted in poor expression of key effector molecules such as IFN-gamma, granzyme A and C,
229 Although the NKR-P1B(+) NK cells can produce effector molecules such as IFNs and granzymes, their pro
230 sferred CD8(+) T cells in vivo, upregulating effector molecules such as perforin, granzyme B, and IFN
231 nd specificity for a tumor target that carry effector molecules such as toxins, cytokines, or radiola
232 ed cells through RLR induction of downstream effector molecules such as type I interferon (IFN) and o
233 m or stimulating the production of secondary effector molecules (such as proinflammatory cytokines) d
234 er certain conditions, these cells and their effector molecules, such as IL-17, IL-21, IL-22, GM-CSF,
236 expression profiles and secretion of diverse effector molecules, suggesting functional heterogeneity.
237 ests in the upregulation of a poorly studied effector molecule, TGFbeta1-induced-1, which is a TGFbet
238 sults highlight TRAIL as a key ILC1-utilized effector molecule that can operate in defense against pe
239 de strong evidence that DSPP is a downstream effector molecule that mediates the roles of DMP1 in den
241 protein 3 (TDRD3) is a major methylarginine effector molecule that reads methyl-histone marks and fa
243 vesicles into the external milieu to deliver effector molecules that alter the host and facilitate vi
245 ense system encompassing sensors and various effector molecules that arrange and achieve a fine-tuned
246 uggestion has been to develop genes encoding effector molecules that block parasite development withi
247 ly modified, resulting in the recruitment of effector molecules that can influence transcription.
248 en shown to carry a wide array of biological effector molecules that can play roles in cell-to-cell c
249 e developed a distinct profile of neutrophil effector molecules that closely reflected the one observ
250 high concentrations they act as microbicidal effector molecules that destroy intracellular pathogens,
251 similarities and differences in sensors and effector molecules that determine host resistance to the
252 anti-tumor immune responses are mediated by effector molecules that enable successful elimination of
253 sicular trafficking mechanisms controlled by effector molecules that include small GTPases and their
256 nd proteome are mediated by pathogen-encoded effector molecules that modulate host cells through a va
257 c neutrophils may serve to inactivate select effector molecules that promote the pro-inflammatory act
258 ike growth factor 1) signal to intracellular effector molecules that regulate glucose homeostasis, be
259 h can act either indirectly or via dedicated effector molecules that target degradosome assemblies.
260 lar messengers amplify signals by binding to effector molecules that trigger physiological changes.
261 h most CRP family members are coregulated by effector molecules, the activity of FixK2 is negatively
262 action profile between GR and its downstream effector molecules, the nuclear receptor coregulators, c
263 ll types through activation of intracellular effector molecules, the Smads (small mothers against dec
264 -specific memory CD8 T cells did not express effector molecules, their epigenetic landscape resembled
265 nize such DAMPs and PAMPs, or the downstream effector molecules they engender, to limit inflammation.
266 tudy, we identify Fgl2 as a soluble TFR cell effector molecule through single-cell gene expression pr
267 ory activity of NF-kappaB and its downstream effector molecules TNF-alpha, IL-1beta, and IL-6 at the
268 o measured the production of 8 HCMV-specific effector molecules (TNFalpha, IFNgamma, interleukin 2, g
269 immune regulation in which CTLA-4 acts as an effector molecule to inhibit CD28 costimulation by the c
270 d inducible nitric oxide synthase (NOS2) (an effector molecule to inhibit T. gondii growth) and the n
271 unidentified switch region that engages with effector molecules to drive beta-arrestin signaling.
273 vesicles (EVs) that can transfer a range of effector molecules to host cells has made us re-think ou
275 because of the binding of specific signaling effector molecules to individual phosphorylated P-sites.
276 adelta T cells that produced IL-17 and other effector molecules to promote inflammation and tumor cel
277 proteins Nck1/2 interact with a multitude of effector molecules to regulate diverse cellular function
278 on between receptor proteins and adaptor and effector molecules to regulate signal generation, amplif
280 sCd-1, was developed to deliver antiparasite effector molecules to the malaria vector mosquito, Anoph
281 es symbiotic bacteria to deliver antimalaria effector molecules to the midgut lumen, thus rendering h
283 ariable domains bind but also in the various effector molecules to which their constant regions (Fc d
287 owever, little is known about mechanisms and effector molecules triggering fibrosis and angiogenesis
288 (2014) demonstrate that CTLA-4 is a critical effector molecule used by regulatory T cells to control
290 factor 1 (CNF1), an Escherichia coli-derived effector molecule, we showed the host indirectly sensed
291 st cancer, expression of IL12A and cytotoxic effector molecules were predictive of pathological compl
292 rients and facilitating the translocation of effector molecules, whereas the exo-oligoxylanase XynA p
294 ke and NK cells expressing antimycobacterial effector molecules, which may be novel targets for tuber
295 protoxin-neutralizing antibodies are the key effector molecules while a shift to Th1 or Treg cells ma
296 repressors, these RNA elements must bind an effector molecule with high specificity against a backgr
298 ural injury involves multiple cell types and effector molecules with both positive and negative effec
299 em cell memory (TSCM) CD8 T cells identified effector molecules with demethylated promoters and poise